EST ANALYSIS OF A BASIDIOMYCETE CRYPTOCOCCUS NEOFORMANS

担子菌新型隐球菌的EST分析

基本信息

项目摘要

DESCRIPTION (Adapted from applicants' abstract): Cryptococcus neoformans is a ubiqutious fungal pathogen that causes life-threatening disease in man. Althogh AIDS patients and immunodeficient individuals are the most susceptible, normal individuals acquire this life-threatening disease as well. Without T lymphocyte function, currently available antifungal drugs do not cure the disease. Moreover, multiple drug resistance is appearing on clinical isolates. Even though several virulence factors have been identified, those factors do not account for all aspects fo the pathogenesis. C. neoformans is an encapsulated Basidiomycete, making it unique genetically among human pathogens. Consequently, gene databases for the other fungi do not serve as guides for studying C. neoformans. A thorough understandind of the genome of C. neoformans would be an extremely valuable resource for moving forward research on C. neoformans. The most efficient, econominal approach to generating a useful genetic inventory is through a combination of expressed seuqence tags (ESTs) and genomic sequencing. Although low density seuqencing of the C. neoformans genome is being done, the annotation with be completely dependent on reliable gene-fingidn software. Based on preliminarydata, it is hypothesized that C. neformans intron/exon junctions are sufficiently different from known eukaryotic seuqneces that gene-finding software will have to be trained for C. neoformans before the software will be useful. We proposed to: 1) generate ESTs from a primary JEV21 cDNA library, 2) prepare a JEC21 normalized library, 3) sequence 4000 cDNAs from the normalized library, 4) fully sequence by primer walking PCR products from selected cDNA clones and genomic DNA and identify the intron/exon boundaries, and 5) train gene-finding sofltware to recongize intron/exon junctions of C. neoformans. ESTs will be useful to identify ORFs, new drug targets, new virulence markers, cell surface adherence factors, and metabolic and signaling pathways.
描述(改编自申请人摘要):新生隐球菌是一种

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JUNEANN W MURPHY其他文献

JUNEANN W MURPHY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JUNEANN W MURPHY', 18)}}的其他基金

EST ANALYSIS OF A BASIDIOMYCETE CRYPTOCOCCUS NEOFORMANS
担子菌新型隐球菌的EST分析
  • 批准号:
    6374446
  • 财政年份:
    2000
  • 资助金额:
    $ 31.6万
  • 项目类别:
EST ANALYSIS OF A BASIDIOMYCETE CRYPTOCOCCUS NEOFORMANS
担子菌新型隐球菌的EST分析
  • 批准号:
    6511225
  • 财政年份:
    2000
  • 资助金额:
    $ 31.6万
  • 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
  • 批准号:
    6184390
  • 财政年份:
    1997
  • 资助金额:
    $ 31.6万
  • 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
  • 批准号:
    6056513
  • 财政年份:
    1997
  • 资助金额:
    $ 31.6万
  • 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
  • 批准号:
    2771665
  • 财政年份:
    1997
  • 资助金额:
    $ 31.6万
  • 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
  • 批准号:
    6389843
  • 财政年份:
    1997
  • 资助金额:
    $ 31.6万
  • 项目类别:
IMMUNOMODULATION DURING PULMONARY CRYPTOCOCCOSIS
肺隐球菌病期间的免疫调节
  • 批准号:
    2542779
  • 财政年份:
    1997
  • 资助金额:
    $ 31.6万
  • 项目类别:
NATURAL CELL-MEDIATED RESISTANCE IN CRYPTOCOCCOSIS
隐球菌病中自然细胞介导的耐药性
  • 批准号:
    3480986
  • 财政年份:
    1989
  • 资助金额:
    $ 31.6万
  • 项目类别:
NATURAL CELL-MEDIATED RESISTANCE IN CRYPTOCOCCOSIS
隐球菌病中自然细胞介导的耐药性
  • 批准号:
    3480988
  • 财政年份:
    1989
  • 资助金额:
    $ 31.6万
  • 项目类别:
NATURAL CELL MEDIATED RESISTANCE IN CRYPTOCOCCOSIS
隐球菌病中天然细胞介导的耐药性
  • 批准号:
    2060804
  • 财政年份:
    1989
  • 资助金额:
    $ 31.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了